Rastogi P, O'Shaughnessy J, Martin M, Boyle F, et al. Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficac J Clin Oncol 2024 Jan 9:JCO2301994. doi: 10.1200/JCO.23.01994.
PMID: 38194616